Background illustration for clinical trials search

Paid Clinical Trials Aurora

Discover 1,604 paid clinical trials in Aurora, Colorado. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 1,604

Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors

for

Unhealthy Alcohol Use, Alcohol Use Disorders

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: Male

Age: 18 - 70+

Code: NCT02465177

Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for

Metastatic Salivary Gland Carcinoma,

Location: Aurora CO, Highlands Ranch CO, Hays KS, Albuquerque NM,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase 2, Recruiting

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

for

Multiple Myeloma

Location: Aurora CO, Denver CO, Phoenix AZ, Madison WI,

Sponsor: European Myeloma Network B.V.

Sex: All

Age: 18+

Code: NCT05243797

Phase 3, Recruiting

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

for

Primary Immune Thrombocytopenia (ITP)

Location: Aurora CO, Oklahoma City OK, Phoenix AZ, Minneapolis MN,

Sponsor: argenx

Sex: All

Age: 18+

Code: NCT06544499

Phase 3, Recruiting

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

for

Failed or Difficult Intubation, Sequela, Intubation; Difficult,

Location: Aurora CO, Omaha NE, Phoenix AZ, Irving TX, Dallas TX,

Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0+

Code: NCT02493478

Recruiting

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

for

Ewing Sarcoma, Colorectal Adenocarcinoma

Location: Aurora CO, Duarte CA, Orange CA, Beverly Hills CA,

Sponsor: Inhibrx Biosciences, Inc

Sex: All

Age: 12 - 70+

Code: NCT03715933

Phase 1, Recruiting

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

for

Retroperitoneal Sarcoma, Liposarcoma, Leiomyosarcoma

Location: Aurora CO, Salt Lake City UT, Omaha NE, Bellevue NE,

Sponsor: European Organisation for Research and Treatment of Cancer - EORTC

Sex: All

Age: 18+

Code: NCT04031677

Phase 3, Recruiting

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

for

Acute Kidney Injury, Hemolysis, Thrombocytopenia, Surgery

Location: Aurora CO

Sponsor: University of Colorado, Denver

Sex: All

Age: 18 - 70+

Code: NCT06349577

Recruiting

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

for

Metastatic Dedifferentiated Liposarcoma,

Location: Aurora CO, St Louis MO, Los Angeles CA, Houston TX,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT05711615

Phase 1, Recruiting

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

for

Recurrent Lung Non-Small Cell Carcinoma,

Location: Aurora CO, Greeley CO, Loveland CO, Colorado Springs CO,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 0+

Code: NCT06031688

Phase 2, Recruiting

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

for

Ovary Cancer, Peritoneal Cancer, Fallopian Tube Cancer

Location: Aurora CO, Irvine CA, Madison WI, Chicago IL,

Sponsor: University of Colorado, Denver

Sex: Female

Age: 18 - 70+

Code: NCT05887609

Phase 2, Recruiting

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

for

Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome

Location: Aurora CO, Saint Paul MN, San Diego CA, Houston TX,

Sponsor: Ionis Pharmaceuticals, Inc.

Sex: Male

Age: 2 - 65

Code: NCT06430385

Phase 1, Phase 2, Recruiting

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for

Ovarian Carcinoma

Location: Aurora CO, Highlands Ranch CO, Colorado Springs CO,

Sponsor: NRG Oncology

Sex: Female

Age: 35 - 50

Code: NCT04251052

Recruiting

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

for

Metastatic Solid Tumor, Advanced Solid Tumor,

Location: Aurora CO, Santa Monica CA, Houston TX, New Lenox IL,

Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06561685

Phase 1, Recruiting

Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty

for

Total Knee Arthroplasty, Functional Recovery, Aging,

Location: Aurora CO, Murray UT

Sponsor: University of Colorado, Denver

Sex: All

Age: 18+

Code: NCT06953375

Recruiting

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

for

Classic Follicular Lymphoma,

Location: Aurora CO, Greeley CO, Loveland CO, Fort Collins CO,

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06337318

Phase 3, Recruiting

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

for

Acral Lentiginous Melanoma,

Location: Aurora CO, Denver CO, Englewood CO, Centennial CO,

Sponsor: SWOG Cancer Research Network

Sex: All

Age: 18+

Code: NCT04511013

Phase 2, Recruiting

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for

Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8,

Location: Aurora CO, Highlands Ranch CO, Colorado Springs CO,

Sponsor: NRG Oncology

Sex: Male

Age: 18+

Code: NCT05946213

Phase 3, Recruiting

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

for

Intracranial Meningioma, Recurrent Meningioma,

Location: Aurora CO, Lakewood CO, Westminster CO, Longmont CO,

Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT02523014

Phase 2, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for

Metastatic Renal Cell Carcinoma,

Location: Aurora CO, Denver CO, Lone Tree CO, Highlands Ranch CO,

Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase 2, Recruiting

Paid Clinical Trials Aurora

Filter results

Tailoring Screening, Brief Intervention, and Referral to Treatment for Medical ICU Survivors

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation

A Study to Assess the Efficacy and Safety of Efgartigimod IV in Adult Participants With Primary Immune Thrombocytopenia

Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs

Interested in new trials?

Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas

Surgery With or Without Neoadjuvant Chemotherapy in High Risk RetroPeritoneal Sarcoma

Optimizing Pulsatility During Cardiopulmonary Bypass to Reduce Acute Kidney Injury

Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)

An Evaluation of Maintenance Therapy Combination Mirvetuximab Soravtansine and Olaparib

ATTUNE: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Intrathecally-Administered ION440 in Participants With Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome (MDS)

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors

Implementation of Neuromuscular Electrical Stimulation After Total Knee Arthroplasty

Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial